The latest market price of Zolbetuximab in 2026 and reference for drug purchase costs through different channels

Zolbetuximab (Zolbetuximab) is a targeted therapy drug mainly used to treat specific types of gastric cancer and gastroesophageal junction adenocarcinoma. Its mechanism of action is by targeting the CLDN18.2 molecule to selectively kill tumor cells expressing this molecule while minimizing damage to normal tissue, thereby improving efficacy and safety. The use of zotuximab usually requires the guidance of a professional oncologist, and the indications are determined based on pathological examination results.

In the domestic market, the original drug Zotuximab has been launched, but it has not yet been included in medical insurance reimbursement. Domestic pharmacies and some large tertiary hospitals can provide medicine supply. The specification of each box is 100mg, and the price is about more than 5,000 yuan. Patients must present a prescription when purchasing, and must obtain it through formal channels to ensure drug quality and efficacy. Since it is not covered by medical insurance, the cost of treatment is entirely paid by the patient, and the financial burden is relatively high.

In overseas markets, the generic drug Zotuximab is available in European and Japanese versions, with the same specifications100mg, and each box may be sold for more than 7,000 yuan (affected by exchange rate fluctuations). Overseas drug purchases are usually made through regular pharmacies or medical institutions and must comply with local drug management regulations. The price of overseas original drugs is higher, but the quality and efficacy of the drugs are consistent with those in China, making them suitable for patients who need to purchase drugs across borders.

Currently, there are no generic drugs of zotuximab on the market, so it is impossible to reduce the cost of treatment through low-priced generic drugs. When patients choose drug purchasing channels, they should give priority to formal drug stores and hospital channels to avoid the risks of informal channels. Overall, price differences at home and abroad, medical insurance policies and drug purchase channels are the main factors that affect patients’ medication costs. Patients should reasonably plan treatment plans based on their own economic conditions and clinical needs.

Keyword tags: zotuximab,CLDN18.2targeting, gastric cancer, gastroesophageal junction cancer, targeted therapy

Reference materials:https://en.wikipedia.org/wiki/Zolbetuximab